Good MorningThe S&P 500 held steady on Tuesday. The market is awaiting today's expected tariff announcement and appears poised to move once the news breaks. The question is whether the tariffs are as bad as the market feared or worse. If only as bad as feared, there is a chance the index could begin to rebound on the news. As it is, the S&P 500 is down about 10% from its peaks.
Labor market data is the other market-moving news this week. The data is expected to show resilient conditions that otherwise suggest economic health. The risk for the market is twofold. If the data is hot, it will raise fears of inflation, high interest rates, and a potential recession, while weak data will point to a recession.
The narrative may begin to change as soon as next week. The first significant earnings reports of the Q1 reporting cycle are due and will set the tone for the season. Featured: $500 to "Partner" with Elon Musk? Shocking… (Brownstone Research) 
|
Markets | | | The trade war that U.S. President Donald Trump has escalated in his second term is a challenge for all Asian economies, large and small, in an era when the most populous region of the world is expected to drive global economic growth.Export manufacturing and free trade helped transform China and oth... Read the Full Story |
|
From Our PartnersThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. | | | | Click here to check out my full write-up. |
|
Markets | | | Asian shares were mostly falling Wednesday, shaken by jitters over what President Donald Trump will announce about tariffs on what he referred to as "Liberation Day."Japan's benchmark Nikkei 225 recouped early losses and was down less than 0.1%, at 35,618.04 in morning trading. Australia's S&P/... Read the Full Story |
|
Markets | | | Global shares were mixed Wednesday as investors waited to see what U.S. President Donald Trump will announce about tariffs on what he refers to as "Liberation Day."European shares opened lower, while Asian markets logged modest gains. France's CAC 40 declined 0.5% in early trading to 7,837.50, while... Read the Full Story |
|
From Our PartnersDoctors are human. They can be overworked and tired which causes them to overlook critical information. That's where AI comes in. This company is developing groundbreaking AI technology to assist doctors. In an industry estimated to grow to $187 billion by 2030, imagine the growth potential! | | | | Don't miss out-see what makes this AI stock stand out. |
|
Markets | | | Like many technology stocks, Apple Inc. (NASDAQ: AAPL) is off to a rough start in 2025. AAPL stock is down 11.8% on concerns over slowing iPhone sales, particularly in China, and confusion bordering on concern over the company’s plans to integrate artificial intelligence (AI) into its... Read the Full Story |
|
Markets | | | Amazon.com Inc. (NASDAQ: AMZN) is back in the spotlight after falling to fresh 2025 lows during Monday's session. The stock, now down more than 20% from its all-time high in February, is officially in a technical bear market. This latest drop is particularly notable because it has brought shares... Read the Full Story |
|
From Our PartnersHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next.
But here's the truth… This is just the beginning.
Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better.
Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times.
Don't wait for the next crash to wipe you out. Act now. | | | | Get Your FREE Presidential Transition Guide Today |
|
Markets | | | After weeks of White House hype and public anxiety, President Donald Trump is set Wednesday to announce a barrage of self-described "reciprocal" tariffs on friend and foe alike.The new tariffs — coming on what Trump has called "Liberation Day" — is a bid to boost U.S. manufacturing and punish other ... Read the Full Story |
|
Markets | | | Rusting pipes in a barren field and unpaid workers are what remain after a U.S. company promised to turn a huge piece of land in Senegal — about twice the size of Paris — into an agricultural project and create thousands of jobs Read the Full Story |
|
Markets | | | Salesforce (NYSE: CRM) is among the most resilient software stocks for reductions in business spending and the market downturns they cause, at least in the eyes of analysts at Evercore ISI. They believe the company’s AI offering and breadth set it apart from competitors, and that moat is r... Read the Full Story |
|
Markets | | | The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) is trading down 5.19%, and the NASDAQ 100, as tracked by the Invesco QQQ (NASDAQ: QQQ), is down 8.2% year-to-date (YTD) as of March 28, 2025. The markets attempted a relief rally that was rejected at the 200-day moving average on the SPY. A number o... Read the Full Story |
|
Markets | | | Investors may see a disconnect between the headlines that D-Wave Quantum Inc. (NYSE: QBTS) has generated and its share price performance in recent weeks. The quantum computing firm came out with two seemingly significant technological updates so far in 2025—first, a report that it had a... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially re... | Should I Buy Guardant Health Stock? GH Bull and Bear Case Explained These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Guardant Health was last updated on Wednesday, April 02, 2025 at 1:06 AM. Guardant Health Bull Case - Guardant Health, Inc. has recently seen a significant increase in institutional investment, with Nikko Asset Management Americas Inc. increasing its stake by 15.6%, indicating strong confidence in the company's future performance.
- The company has a robust portfolio of innovative products, including the Guardant360 Response Test, which is designed for advanced cancer treatment, showcasing its commitment to precision oncology.
- Recent analyst reports have been optimistic, with Canaccord Genuity raising the price target to $60.00, reflecting a positive outlook on the stock's potential growth.
- Guardant Health, Inc. is at the forefront of cancer research collaborations, including a partnership with Illumina, Inc., which enhances its research capabilities and market position.
- The current stock price of Guardant Health, Inc. is approximately $44.73, which may present a buying opportunity for investors looking to enter at a favorable valuation.
Guardant Health Bear Case - Despite recent growth, Guardant Health, Inc. operates in a highly competitive market, which could impact its market share and profitability in the long term.
- The company is heavily reliant on the success of its product pipeline, and any delays or failures in product development could adversely affect its stock performance.
- Institutional investors currently hold 92.60% of the company's stock, which may lead to volatility if large shareholders decide to sell their positions.
- Market conditions and regulatory changes in the healthcare sector could pose risks to the company's operations and financial stability.
- Guardant Health, Inc. has yet to achieve consistent profitability, which may deter risk-averse investors looking for stable returns.
| | View Today's Stock Pick |
|
